Skip to main content
ENTA logo

ENTA · Enanta Pharmaceuticals Inc

$12.50 -0.11 (-0.87%)
Market Cap
$366.68M
Shares
29.08M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 132
Total Value: $326,911,809
Total Shares: 25,878,361
Showing 1–100 of 135 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 132 13F filers
Top Holder
14.6%
Jun 2023 → Mar 2026 · range 9.3% – 18.4%
of institutional value
Top 5
56.4%
Jun 2023 → Mar 2026 · range 38.8% – 56.4%
of institutional value
Top 10
74.1%
Jun 2023 → Mar 2026 · range 60.3% – 74.1%
of institutional value
HHI
753
Jun 2023 → Mar 2026 · range 476 – 753
Broadly held
Showing 100 of 135
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1177648 CUSIP 29251M106 13F (30d) 38 filings 17 filers Visit website Investor relations